Stereochemical assignment and anti-inflammatory properties of the omega-3 lipid mediator resolvin E3.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Journal of Biochemistry (Tokyo)

• Publication date

  2013-04-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1093/jb/mvs151PMID 23293324
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Total syntheses of four possible stereoisomers of resolvin E3

  2012cited by this paper
• Identification and Structure Determination of Novel Anti-inflammatory Mediator Resolvin E3, 17,18-Dihydroxyeicosapentaenoic Acid*

  2012cited by this paper
• Mediator lipidomics in acute inflammation and resolution.

  2012cited by this paper
• Pro-resolving actions and stereoselective biosynthesis of 18S E-series resolvins in human leukocytes and murine inflammation.

  2011cited by this paper
• Specialized pro-resolving lipid mediators in the inflammatory response: An update.

  2010cited by this paper
• The opposing effects of n-3 and n-6 fatty acids.

  2008cited by this paper
• Control of oxygenation in lipoxygenase and cyclooxygenase catalysis.

  2007cited by this paper
• Resolvin E2: identification and anti-inflammatory actions: pivotal role of human 5-lipoxygenase in resolvin E series biosynthesis.

  2006cited by this paper
• Stereochemical assignment, antiinflammatory properties, and receptor for the omega-3 lipid mediator resolvin E1

  2005cited by this paper
• The contributions of aspirin and microbial oxygenase to the biosynthesis of anti-inflammatory resolvins: novel oxygenase products from omega-3 polyunsaturated fatty acids.

  2005cited by this paper
• Molecular Circuits of Resolution: Formation and Actions of Resolvins and Protectins1

  2005cited by this paper
• Blood levels of long-chain n-3 fatty acids and the risk of sudden death.

  2002cited by this paper
• Novel Functional Sets of Lipid-Derived Mediators with Antiinflammatory Actions Generated from Omega-3 Fatty Acids via Cyclooxygenase 2–Nonsteroidal Antiinflammatory Drugs and Transcellular Processing

  2000cited by this paper
• Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico.

  1999cited by this paper

• Catalytic versatility of lipoxygenase from Microcystis aeruginosa.

  2025cites this paper
• The association of circulating systemic inflammation with premature death and the protective role of the Mediterranean diet: a large prospective cohort study of UK biobank

  2024cites this paper
• PUFA and intrahepatic cholestasis of pregnancy: a two-sample Mendelian randomisation analysis

  2024cites this paper
• Role of Resolvins in Inflammatory and Neuropathic Pain

  2023cites this paper
• Resolvins and Cysteinyl-containing Pro-Resolving Mediators Activate Resolution of Infectious Inflammation and Tissue Regeneration.

  2023cites this paper
• Something Smells Fishy: How Lipid Mediators Impact the Maternal–Fetal Interface and Neonatal Development

  2023cites this paper
• Characteristic fragmentation of polyunsaturated fatty acids with allylic vicinal diols in positive-ion LC/ESI-MS/MS

  2023cites this paper
• Major structure-activity relationships of resolvins, protectins, maresins and their analogues.

  2022cites this paper
• Amelioration for oxidative stability and bioavailability of N-3 PUFA enriched microalgae oil: an overview

  2022cites this paper
• Design and Synthesis of Cyclopropane Congeners of Resolvin E3, an Endogenous Pro-Resolving Lipid Mediator, as Its Stable Equivalents.

  2022cites this paper
• E-series resolvin metabolome, biosynthesis and critical role of stereochemistry of specialized pro-resolving mediators (SPMs) in inflammation-resolution: Preparing SPMs for long COVID-19, human clinical trials, and targeted precision nutrition

  2022cites this paper
• Specialized Pro-Resolving Lipid Mediators: The Future of Chronic Pain Therapy?

  2021cites this paper
• Subgingival Microbiome and Specialized Pro-Resolving Lipid Mediator Pathway Profiles Are Correlated in Periodontal Inflammation

  2021cites this paper
• RvD1 treatment during primary infection modulates memory response increasing viral load during respiratory viral reinfection.

  2021cites this paper
• Dexamethasone and fish oil improve average daily gain but not muscle mass or protein content in feedlot wethers after chronic heat stress

  2021cites this paper
• A New E-Series Resolvin: RvE4 Stereochemistry and Function in Efferocytosis of Inflammation-Resolution

  2021cites this paper
• Omega 3 Fatty Acid and Skin Diseases

  2021cites this paper
• Stereoselective Synthesis and Structural Confirmation of the Specialized Pro-Resolving Mediator Resolvin E4

  2021cites this paper
• 14,17,18-Trihydroxy-Eicosatetraenoic Acid: A Novel Pro-Resolving Lipid Mediator from Marine Microalgae.

  2021cites this paper
• Human lipoxygenase isoforms form complex patterns of double and triple oxygenated compounds from eicosapentaenoic acid.

  2020cites this paper
• Stereoselective syntheses and biological activities of E-series resolvins.

  2020cites this paper
• Synthesis of Resolvin E3, a Proresolving Lipid Mediator, and Its Deoxy Derivatives: Identification of 18-Deoxy-resolvin E3 as a Potent Anti-inflammatory Agent.

  2020cites this paper
• Eicosapentaenoic acid’s metabolism of 15-LOX-1 promotes the expression of miR-101 thus inhibits Cox2 pathway in colon cancer

  2020cites this paper
• Dysregulated metabolism of polyunsaturated fatty acids in eosinophilic allergic diseases.

  2020cites this paper
• OTT_A_237562 5605..5616

  2020cites this paper
• Marine omega-3 (n-3) phospholipids: A comprehensive review of their properties, sources, bioavailability, and relation to brain health.

  2020cites this paper
• Omega-3 fatty acid-derived mediators that control inflammation and tissue homeostasis.

  2019cites this paper
• Synthesis of resolvin E3 via palladium-catalyzed addition of AcOH to vinyl epoxy alcohols.

  2019cites this paper
• Roles, Actions, and Therapeutic Potential of Specialized Pro-resolving Lipid Mediators for the Treatment of Inflammation in Cystic Fibrosis

  2019cites this paper
• Development of an Optimized LC-MS Method for the Detection of Specialized Pro-Resolving Mediators in Biological Samples

  2019cites this paper
• Resolution metabolomes activated by hypoxic environment

  2019cites this paper
• Specialized pro-resolving lipid mediators: a new class of non-immunosuppressive and non-opioid analgesic drugs.

  2019cites this paper
• Oxidative modifications of extracellular matrix promote the second wave of inflammation via β2 integrins.

  2018cites this paper
• Resolvin E1, but not resolvins E2 and E3, promotes fMLF‐induced ROS generation in human neutrophils

  2018cites this paper
• Specialized Proresolving Mediators in Innate and Adaptive Immune Responses in Airway Diseases.

  2018cites this paper
• Comprehensive analysis of the mouse cytochrome P450 family responsible for omega-3 epoxidation of eicosapentaenoic acid

  2018cites this paper
• Resolvin E3 attenuates lipopolysaccharide-induced depression-like behavior in mice.

  2018cites this paper
• Pro-resolving Mediators

  2018cites this paper
• Identification and structure elucidation of the pro‐resolving mediators provides novel leads for resolution pharmacology

  2018cites this paper
• Effect of omega-3 fatty acid supplementation during pregnancy or infancy on cardio-metabolic risk factors in childhood

  2017cites this paper
• Roles of Specialized Proresolving Lipid Mediators in Inflammation Resolution and Tissue Repair

  2017cites this paper
• Biological and pathophysiological roles of end-products of DHA oxidation.

  2017cites this paper
• Resolving Inflammation in Heart Failure: Novel Protective Lipid Mediators.

  2016cites this paper
• Emerging roles of pro-resolving lipid mediators in immunological and adaptive responses to exercise-induced muscle injury.

  2016cites this paper
• Divergent shifts in lipid mediator profile following supplementation with n‐3 docosapentaenoic acid and eicosapentaenoic acid

  2016cites this paper
• Lipoxins, Resolvins, and the Resolution of Inflammation

  2016cites this paper
• ADVANCES IN FOOD TECHNOLOGY AND NUTRITIONAL SCIENCES

  2016cites this paper
• Role of omega-3 fatty acids and their metabolites in asthma and allergic diseases.

  2015cites this paper
• Roles of resolvins in the resolution of acute inflammation

  2015influential citation
• Total synthesis of four stereoisomers of (5Z,8Z,10E,14Z)-12-hydroxy-17,18-epoxy-5,8,10,14-eicosatetraenoic acid and their anti-inflammatory activities

  2015cites this paper
• Advances in Our Understanding of Oxylipins Derived from Dietary PUFAs.

  2015cites this paper
• Omega-3 Fatty Acid Metabolism and Regulation of Inflammation

  2015cites this paper
• Systematic review of prostate cancer risk and association with consumption of fish and fish‐oils: analysis of 495,321 participants

  2015cites this paper
• The resolution code of acute inflammation: Novel pro-resolving lipid mediators in resolution.

  2015cites this paper
• Identification of novel omega-3 fatty acid-derived bioactive metabolites based on a targeted lipidomics approach

  2014cites this paper
• 18-HEPE, an n-3 fatty acid metabolite released by macrophages, prevents pressure overload–induced maladaptive cardiac remodeling

  2014cites this paper
• Novel Pro-Resolving Lipid Mediators in Inflammation Are Leads for Resolution Physiology

  2014cites this paper
• Acute Inflammation: A Protective Host Response that May Turn into Harm

  2014cites this paper
• Enzymatic Oxidation of Polyunsaturated Fatty Acids

  2014cites this paper
• Immunoresolving Lipid Mediators and Resolution of Inflammation in Aging

  2014cites this paper
• Short-term n-3 fatty acid supplementation but not aspirin increases plasma proresolving mediators of inflammation[S]

  2014cites this paper
• Resolution of acute inflammation in the lung.

  2014influential citation
• Pro-resolving lipid mediators are leads for resolution physiology

  2014cites this paper
• Resolution phase lipid mediators of inflammation: agonists of resolution.

  2013cites this paper
• Increased tissue levels of omega-3 polyunsaturated fatty acids prevents pathological preterm birth

  2013cites this paper